Showing items 1 - 5 of 5

Your selections:

Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes

- Gedye, Craig, Navani, Vishal

Melanoma: An immunotherapy journey from bench to bedside

- Navani, Vishal, Graves, Moria C., Mandaliya, Hiren, Hong, Martin, van der Westhuizen, Andre, Martin, Jennifer, Bowden, Nikola A.

Business as unusual: medical oncology services adapt and deliver during COVID-19

- Travers, Avraham, Adler, Kim, Blanchard, Gillian, Bonaventura, Tony, Charlton, Julie, Day, Fiona, Healey, Laura, Kim, Sang, Lombard, Janine, Mallesara, Girish, Mandaliya, Hiren, Navani, Vishal, Nordman, Ina, Paterson, Robin, Plowman, Louise, Quah, Gaik Tin, Scalley, Michael, Shrestha, Prajwol, Tailor, Bharti, van der Westhuizen, Andre

Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers

- Navani, Vishal, Graves, Moira C., Marchett, Giovana Celli, Mandaliya, Hiren, Bowden, Nikola A., van der Westhuizen, Andre

Immune checkpoint blockade in solid organ tumours: choice, dose and predictors of response

- Navani, Vishal, Graves, Moira C., Bowden, Nikola A., Van Der Westhuizen, Andre

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit